About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04278079

Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy

Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy

Lead sponsor: Tanta University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Tanta University

Performing pars plana vitrectomy for highly myopic patients with decreased visual acuity is the standard of care for patients with myopic traction. A variety of findings are seen by Optical Coherence Tomography. Epiretinal membranes, retinoschisis, lamellar macular holes, and full thickness macular holes are seen. Undergoing vitrectomy, with or without tamponade, in our center, is retrospectively evaluated. Visual acuity change, as well as improvement of the retinal structure by OCT will be examined.

Age

30 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Highly myopic patients, having a refractive errors (spherical equivalent) of more than - 8 Diopter, or an axial length more than 26.5 mm.
•Best Corrected Visual Acuity less than 0.1
•Spectral Domain Optical Coherence Tomography showed; staphylomatous changes, with either: Macular retinoschisis, foveal retinal detachment, full thickness macular hole (with or without macualr hole retinal detachment), or lamellar macular hole, with epiretinal membrane
•At least 6 months follow-up

Exclusion Criteria

•Eyes with diffuse chorioretinal macular atrophy
•Concomitant presence of a choroidal neovascular membrane
•Young patients less than 21 years old.
•History of trauma
•Dense media opacity (corneal/ lenticular)

Related studies

Necessity of Post-operative Eye Drops

NCT07396831 · Pars Plana Vitrectomy, Scleral Buckling, and more

Not Yet RecruitingNA

INTRAOCULAR PRESSURE MEASUREMENT AT the END of PARS PLANA VITRECTOMY

NCT06707168 · Pars Plana Vitrectomy

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

NCT05990829 · Diabetic Macular Edema, Pars Plana Vitrectomy, and more

Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients

NCT05631054 · Proliferative Diabetic Retinopathy, Pars Plana Vitrectomy, and more

Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy

NCT04774146 · PArs Plana Vitrectomy, Retinal Detachment, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 20, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment52

Start dateJan 2015

Last updatedFeb 20, 2020

Condition

Myopic Traction Maculopathy Pars Plana Vitrectomy Internal Limiting Membrane Peeling

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2020Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions